Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315119 · ClinicalTrials.gov registry record
SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 100
- Enrollment target
NCT01315119: Completed study, sponsored by Stanford University.
NCT01315119 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01315119 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators hope to learn the value of the SPY ELITE® intra-operative angiography in reducing post-operative complications associated with low breast skin blood flow after breast reconstruction using implants.
Interventions
- PROCEDURE SPY Intra-Operative Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01315119
The ClinicalTrials.gov registry entry for NCT01315119 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SPY Intra-Operative Angiography is the first listed.
NCT01315119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01315119 about?
NCT01315119 is a clinical study titled "SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants". The investigators hope to learn the value of the SPY ELITE® intra-operative angiography in reducing post-operative complications associated with low breast skin blood flow after breast reconstruction using implants.
What is the current status of trial NCT01315119?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2011-06. Estimated completion is 2015-09-23.
What interventions are being tested in trial NCT01315119?
The interventions under investigation include: SPY Intra-Operative Angiography (PROCEDURE).
Who is sponsoring clinical trial NCT01315119?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.